FGFR3 and neoplasm: These differences may reflect increased numbers of immunosuppressive macrophages and regulatory T cells, as well as reduced infiltration of inflammatory CAF and T cells in the tumor microenvironment of cancer patients with FGFR3 alterations [276, 277].